Long QT Syndrome Type 3
3 clinical trials · Condition
◉ Watch Long QT Syndrome Type 3
| Record | Firm | Date |
|---|---|---|
| Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3 (NCT07075445) | Thryv Therapeutics, Inc. | 2025-10-27 |
| Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 (NCT02300558) | Gilead Sciences | 2014-12-17 |
| Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine (NCT01728025) | Tel-Aviv Sourasky Medical Center | 2012-10-01 |
Track Long QT Syndrome Type 3 automatically
Every clearance here is in the API, with alerts when new ones post.